| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGPAT4 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | PPOX | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | POLR2C | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | ARSD | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PDGFRB | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | TTC9C | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | INTS10 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CGN | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | C6orf10 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | AP2A1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
